New Delhi [India], December 27 (ANI/GIPR): In the midst of a coronavirus-caused Covid-19 pandemic when many companies are struggling to make ends meet, there are some companies that have become a force to reckon with and to bet on without getting into any kind of financial hassles – PrevestDenpro, one of India’s leading manufacturers of dental materials, is one of them.
PrevestDenpro is addressing USD 20 billion global market growing at 8% CAGR with products which find applications in endodontics, prosthodontics, orthodontics, restorative dentistry, aesthetic dentistry trusted by dental professionals across the world in more than 75 countries with the most enviable financials.
Also Read | BNBXMAS Crypto Platform Reportedly Begins Global Operations, Claims Daily Returns of Up to 17%.
But what caught the attention of RH Perennial Fund is the potential hyper scaling over next 3-4 years.
PrevestDenpro: Business Portfolio – Stupendous Growth Expected
Also Read | Realme GT 2 Pro To Get 6.7-Inch 2K AMOLED Display, Realme GT 2 Reportedly Spotted on NBTC.
“The business pre-IPO had a gross block of INR 8 crores and turnover of 27.5 cr. It raised ~INR 26 crores from its IPO with INR 16 crores for new capex. Essentially if the management executes over the next 3-4 years, it could more than triple its revenues in an industry where the company has a gross margins more than 70%, says RH Perennial Fund report.
PrevestDenpro: Exponential Growth So Far
Over the past 5…
